Stephanie Peck
Psychiatry · Erie, PANPI 1821662487
Payments from drug & device makers
Across 99 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$567
- Alkermes, Inc.$173
- E.r. Squibb & Sons, L.L.C.$152
- Neurocrine Biosciences, Inc.$150
- Otsuka America Pharmaceutical, Inc.$128
- Axsome Therapeutics, Inc.$118
- plus $433 from 13 others
What the payments were for
- Food & beverage$1,721100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 36 | $567 |
| Alkermes, Inc. | 8 | $173 |
| E.r. Squibb & Sons, L.L.C. | 11 | $152 |
| Neurocrine Biosciences, Inc. | 8 | $150 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Axsome Therapeutics, Inc. | 6 | $118 |
| Supernus Pharmaceuticals, Inc. | 5 | $98 |
| Ironshore Pharmaceuticals Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Corium, LLC | 2 | $28 |
| Tonix Medicines, Inc. | 1 | $27 |
| Neurelis, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Indivior Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$125
How this compares
$1,721 in reported general payments places this provider in the 80th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 11 | $14,441 |
| Ziprasidone Hcl | 13 | $916 |
| Bupropion XlBupropion Hcl | 44 | $528 |
| Mirtazapine | 26 | $492 |
| Quetiapine Fumarate | 22 | $454 |
| Sertraline Hcl | 48 | $381 |
| Duloxetine Hcl | 40 | $376 |
| Atomoxetine Hcl | 14 | $363 |
| Paroxetine Hcl | 32 | $327 |
| Buspirone Hcl | 30 | $302 |
| Olanzapine | 26 | $280 |
| Escitalopram Oxalate | 28 | $279 |
| Fluoxetine Hcl | 40 | $275 |
| Trazodone Hcl | 42 | $185 |
| Aripiprazole | 21 | $175 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Erie
- Mary Anne AlbaughErie$24K
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.